Qt Imaging Holdings (QTI) Capital Expenditures Growth (1y) (2023 - 2025)
Qt Imaging Holdings (QTI) Capital Expenditures Growth (1y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | -47.73% |
| 10 | Qt Imaging Holdings | 37.92 Mn | 31.02 Mn | 2.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.51% |
| Jun 30, 2025 | 73.55% |
| Sep 30, 2024 | 176.13% |
| Jun 30, 2024 | 439.54% |
| Mar 31, 2023 | 96.97% |